Related Experiment Videos
Grampian Health Board's joint drug formulary.
Summary
Developing a joint formulary for ulcer healing drugs between general practice and hospitals is feasible. Consultation revealed similar drug choices, impacting health board drug expenditure and prescribing decisions.
Area of Science:
- Health Services Research
- Pharmacoeconomics
- Clinical Pharmacy
Background:
- Hospital and general practice formularies often differ, leading to potential inconsistencies in drug selection and cost.
- Developing a unified formulary can streamline drug management and improve cost-effectiveness across healthcare settings.
Purpose of the Study:
- To develop a model for a joint general practice-hospital formulary.
- To use ulcer healing drugs as a case study for formulary development.
Main Methods:
- A joint formulary development group created draft guidelines based on an existing hospital formulary.
- Guidelines were circulated to local general practitioners for consultation.
- Revised guidelines were submitted to the health board's medicines committee for approval and distribution.
Main Results:
- The selection of ulcer healing drugs by general practitioners and hospital doctors showed high coincidence.
- Significant cost variations were observed for one-day treatment courses between hospital and general practice settings.
- Six drugs were more expensive in hospitals, while five were more expensive in general practice.
Conclusions:
- A joint formulary for hospitals and general practice can be developed through consultation, as drug choices are largely consistent.
- Implementing a joint formulary can influence health board drug expenditure.
- A unified formulary can standardize drug choices for patients transitioning between hospital and community care.